EXOWALK®辅助机电步态训练的有效性与安全性:随机对照试验研究方案
本研究为多中心、随机、平行组临床试验,在韩国3个临床研究中心纳入144例卒中患者,比较EXOWALK®机电辅助步态训练与常规步态训练的效果。主要终点为功能性步行分类(FAC),在治疗前、治疗后及治疗4周后测量,次要终点包括11项运动功能与范围指标。
要点
- 多中心随机平行组试验,纳入144例卒中患者,比较EXOWALK®机电辅助步态训练与常规步态训练。
- 两组均接受基础康复(中枢神经系统发育治疗和力量训练),每周5次、每次半小时,共4周。
- 主要终点为功能性步行分类(FAC),在治疗前、治疗后及治疗4周后测量。
核心结论
- 本研究结果可望证明EXOWALK®机电辅助步态训练的普遍有效性和安全性。
研究设计与样本
- 多中心、随机、平行组临床试验,在韩国3个临床研究中心(东国大学一山医院、忠南大学医院、首尔大学盆唐医院)开展,计划纳入144例卒中患者。
- 入组患者按随机化表分为实验组和对照组,每周治疗5次、每次半小时(1次),共4周。
- 两组均进行基础康复(中枢神经系统发育治疗和力量训练),实验组执行机器人步行康复治疗,对照组执行常规步态康复治疗。
主要发现
- 主要终点变量为功能性步行分类(FAC),用于判定独立步行程度,在治疗前、治疗后及治疗4周后测量。
- 次要终点变量为11项考虑运动功能和范围的变量,与主要终点变量同时测量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,关于机电辅助步态训练对卒中患者有效性的数据仍不足,且缺乏大规模研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-intensity repetitive task-specific practice might be the most effective strategy to promote motor recovery after stroke, and electromechanical-assisted gait training represents one of the treatment options. However, there is still difficulty in clarifying the difference between conventional gait training and electromechanically assisted gait training. METHODS: The study is a multicenter, randomized, parallel-group clinical trial for stroke patients. Three clinical research centers in Korea (Dongguk University Ilsan Hospital, Chungnam National University Hospital, and Seoul National University Bundang Hospital) will participate in the clinical trial and 144 stroke patients will be registered. Enrolled patients are assigned to two groups, an experimental group and a control group, according to a randomization table. In addition, patients are treated for half an hour (one session) five times a week for 4 weeks. Both groups carry out basic rehabilitation (central nervous system development therapy and strength exercise) and the experimental group executes robotic walking rehabilitation treatment, and the control group executes conventional gait rehabilitation treatment. The primary endpoint variable is the Functional Ambulation Category (FAC) that determines the degree of independent walking and is measured before, after, and after 4 weeks of treatment. Secondary endpoint variables are 11 variables that take into account motor function and range, measured at the same time as the primary endpoint variable. DISCUSSION: There are still insufficient data on the effectiveness of electromechanical-assisted gait training for stroke patients and large-scale research is lacking. Thus, the research described here is a large-scale study of stroke patients that can supplement the limitations mentioned in other previous studies. In addition, the clinical studies described here include physical epidemiological analysis parameters that can determine walking ability. The results of this study can lead to prove the generalizable effectiveness and safety of electromechanical-assisted gait training with EXOWALK®. TRIAL REGISTRATION: Clinical Research Information Service (CRIS), Republic of Korea KCT0003411, Registered on 30 October 2018.
引用
- Lim CY, Ko MJ, Lee JW, et al. Efficacy and safety of EXOWALK® on electromechanical-assisted gait training: study protocol for randomized controlled trial. Trials. 2022. PMID: 36056399. doi:10.1186/s13063-022-06660-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。